News

Sanofi-aventis claimed that it would manufacture all of its clopidogrel-containing products for the European markets in the European Union in full compliance with the relevant rules and regulations

The MMRF has been awarded MannKind a $1m grant through its 2007 Biotech Investment Award program, a multi-year, results-driven commitment to fund the development of treatments for multiple

Attract-1 was a pivotal study of ASA404 in previously untreated, advanced NSCLC. Patients were randomised 1:1 to receive either ASA404 plus chemotherapy (carboplatin/paclitaxel) or a placebo plus chemotherapy

Reportedly, team leader Michael Krainer and his colleagues are expected to concentrate primarily on tumors diagnosed late or those which recur after surgical interventions, and which do not

EntreMed has posted total revenues of $1.61m, compared to $3.97m for the same period in 2008. For the fiscal year 2009, EntreMed has posted a net loss of

ExonHit Therapeutics claimed that EHT 0202 has a novel mechanism of action when compared to existing Alzheimer’s disease therapeutics and stimulates the a-secretase pathway, thus enhancing the production

Progen said that Sue MacLeman has international senior management and leadership experience in product development and commercialisation in the biotechnology and pharmaceutical sector. Ms MacLeman is also a

As per a new agreement, Ampac Fine Chemicals is expected to use Codexis’ proprietary biocatalysis technology in combination with AFC’s existing technologies to reduce cost, increase manufacturing efficiency

The filing of the IND follows a successful Pre-IND meeting with the FDA, during which guidance was provided to the company regarding the basis of approval and the